ca_rx_new_drug_launches

io.github.pipeworx-io/ca-drug-price-transparency · Verify this server

California manufacturer disclosures of a NEW prescription drug launched with a Wholesale Acquisition Cost (WAC — published list price) exceeding the Medicare Part D specialty-drug cost threshold — California's "launch price" transparency requirement, filed with HCAI's Cost Transparency Rx (CTRx) program (same law as ca_rx_wac_increases, different trigger: a NEW drug's starting price rather than an existing drug's price increase). Search by drug name/fragment or manufacturer, optionally pinned to one report year (2019-present). Returns the launch WAC, estimated patient population, and breakthrough-therapy/priority-review FDA designations when disclosed. California-only. Keyless.